{
    "Trade/Device Name(s)": [
        "S-Test Cholesterol (CHO)",
        "S-Test High Density Lipoprotein Cholesterol (HDL)",
        "S-Test Triglycerides (TG)"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K091413",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH",
        "LBS",
        "CDT"
    ],
    "Summary Letter Date": "October 19, 2009",
    "Summary Letter Received Date": "October 21, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1175",
        "21CFR862.1475",
        "21CFR862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol (total) test system",
        "Lipoprotein test system (HDL)",
        "Lipase hydrolysis/glycerol kinase enzyme triglycerides test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "HDL Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparin Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "S40 Clinical Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic esterase-oxidase",
        "Enzymatic hydrolysis",
        "Photometric measurement"
    ],
    "Methodologies": [
        "Photometric test"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Alfa Wassermann S-Test CHO, HDL, and TG reagent cartridges for quantitative determination of cholesterol, HDL, and triglycerides using S40 Clinical Analyzer",
    "Indications for Use Summary": "Intended for quantitative determination of cholesterol, HDL cholesterol, and triglyceride concentrations in serum or heparin plasma using the S40 Clinical Analyzer; used to aid diagnosis and treatment of lipid metabolism disorders, atherosclerosis, diabetes, liver and renal diseases, and other endocrine disorders; for in vitro diagnostic use in clinical and physician office laboratories.",
    "fda_folder": "Clinical Chemistry"
}